Study Details

General Information

Boehringer Ingelheim 1275.1

Protocol
Identifier1275.1
UID58f693b7-c711-42dc-85f8-2b78e0ee13a6
StatusNot Selected
Phase
Category
Launch Year0
NCT Number-
Created2011-04-06 16:11
Last Updated2011-04-06 16:11

Description

No description provided.

Comment

No comment.

Target Dates

NameDateRequired
Enrollment ClosedNo
Enrollment OpenNo
First Patient First VisitNo
Site Initiation Mtg.No
PI Meeting StartNo
PI Meeting EndNo
PI Meeting ArrivalNo
PI Meeting DepartureNo
Closeout DateNo
Final PatientVisitNo
PreStudy Selection VisitNo
Target Date 12No
Target Date 13No
Target Date 14No

Leadership

RoleStaffLoginRequired
Principal-No
Recruiter-No
CoordinatorMata, NellyNMataNo
RegulatoryAguirre, SandraSAguirreNo

Custom Fields

No custom fields.

Sponsor & Organization

SponsorBoehringer Ingelheim Pharmaceuticals, Inc.
DivisionBoehringer Ingelheim Pharmaceuticals
TeamBoehringer Ingelheim Pharmaceuticals
Managing SiteCatalina Research Institute, LLC
Organization

Contacts

IRB Ref
CRO
CRO Ref
Correspondence0

Opportunity

Probability0
Comment
Status ColorLightgray
Currency-
Mayra Sibley

2 Hours

Hi there, I'm Jesse and you?
You

3 minutes

My name is Anne Clarc.
Mayra Sibley

40 seconds

Nice to meet you Anne.
How can i help you?